Mutations in Penicillin-Binding Protein (PBP) genes and in non-PBP genes during selection of penicillin-resistant Streptococcus gordonii

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 4053-4061

  Haenni, Marisa ^a   Moreillon, Philippe ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; PENICILLIN G; PEPTIDOGLYCAN;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GLYCOSYLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PBP GENE; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REACTION ANALYSIS; STREPTOCOCCUS GORDONII;

GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; SELECTION (GENETICS); STREPTOCOCCUS; TRANSFORMATION, GENETIC;

EID: 33845273792     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00676-06     Document Type: Article

References (35)

1. Amsterdam, D. 1996. Susceptibility testing of antimicrobials in liquid medium, p. 52-111. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, Md.
2. Cao, M., T. Wang, R. Ye, and J. D. Helmann. 2002. Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilis σW and σM regulons. Mol. Microbiol. 45:1267-1276.
3. Chen, J.-D., and D. A. Morrison. 1988. Construction and properties of a new insertion vector, pJDC9, that is protected by transcriptional terminators and useful for cloning of DNA from Streptococcus pneumoniae. Gene 64:155-164.
4. Cottagnoud, P., J. Entenza, M. Cottagnoud, Y.-A. Que, P. Moreillon, and M. Tauber. 2001. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiol. 1:9.
5. Di Guilmi, A. M., N. Mouz, L. Martin, J. Hoskins, S. R. Jaskunas, O. Dideberg, and T. Vernet. 1999. Glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae is membrane associated. J. Bacteriol. 181:2773-2781.
6. Douglas, C. W., J. Heath, K. K. Hampton, and F. E. Preston. 1993. Identity of viridans streptococci isolated from cases of infective endocarditis. J. Med. Microbiol. 39:179-182.
7. Entenza, J., J. Vouillamoz, M. Glauser, and P. Moreillon. 1997. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1662-1667.
8. Farber, B. F., G. M. Eliopoulos, J. I. Ward, K. Ruoff, and R. C. J. Moellering. 1983. Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci. Antimicrob. Agents Chemother. 24:871-875.
9. Filipe, S. R., E. Severina, and A. Tomasz. 2002. The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA. 99:1550-1555.
10. Filipe, S. R., and A. Tomasz. 2000. Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. Proc. Natl. Acad. Sci. USA. 97:4891-4896.
11. Frandsen, E. V., V. Pedrazzoli, and M. Kilian. 1991. Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol. Immunol. 6:129-133.
12. Gordon, E., N. Mouz, E. Duee, and O. Dideberg. 2000. The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. J. Mol. Biol. 299:477-485.
13. Grebe, T., J. Paik, and R. Hakenbeck. 1997. A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J. Bacteriol. 179:3342-3349.
14. Guenzi, E., A. M. Gasc, M. A. Sicard, and R. Hakenbeck. 1994. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol. Microbiol. 12:505-515.
15. Haenni, M., P. A. Majcherczyk, J.-C. Barblan, and P. Moreillon. 2006. Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii. Antimicrob. Agents Chemother. 50:4062-4069.
16. Hakenbeck, R., and J. Coyette. 1998. Resistant penicillin-binding proteins. Cell. Mol. Life Sci. 54:332-340.
17. Hakenbeck, R., T. Grebe, D. Zahner, and J. B. Stock. 1999. Beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins. Mol. Microbiol. 33:673-678.
18. Hakenbeck, R., C. Martin, C. Dowson, and T. Grebe. 1994. Penicillin-binding protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory mutants. J. Bacteriol. 176:5574-5577.
19. Hardy, J. M., and G. H. Bowen. 1974. The normal microbial flora of the mouth. Soc. Appl. Bacteriol. Symp. Ser. 3:47-83.
20. Hardy, J. M., and P. D. Marsh. 1978. Streptococci and the human oral flora, p. 157-206. In F. A. Skinner and L. B. Quesnel (ed.), Streptococci. Academic Press, Inc., New York, N. Y.
21. Hoban, D., F. Baquero, V. Reed, and D. Felmingham. 2005. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int. J. Infect. Dis. 9:262-273.
22. Kell, C. M., U. K. Sharma, C. G. Dowson, C. Town, T. S. Balganesh, and B. G. Spratt. 1993. Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X of Streptococcus pneumoniae. FEMS Microbiol. Lett. 106:171-175.
23. Lau, P. C. Y., C. K. Sung, J. H. Lee, D. A. Morrison, and D. G. Cvitkovitch. 2002. PCR ligation mutagenesis in transformable streptococci: application and efficiency. J. Microbiol. Methods 49:193-205.
24. Levy, C. S., P. Kogulan, V. J. Gill, M. B. Croxton, J. G. Kane, and D. R. Lucey. 2001. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin. Infec. Dis. 33:577-579.
25. Nagai, K., T. A. Davies, M. R. Jacobs, and P. C. Appelbaum. 2002. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob. Agents Chemother. 46:1273-1280.
26. Pagliero, E., L. Chesnel, J. Hopkins, J. Croize, O. Dideberg, T. Vernet, and A. M. Di Guilmi. 2004. Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in beta-lactam resistance. Antimicrob. Agents Chemother. 48:1848-1855.
27. Pares, S., N. Mouz, Y. Petillot, R. Hakenbeck, and O. Dideberg. 1996. X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme. Nat. Struct. Biol. 3:284-289.
28. Perez-Trallero, E., C. Fernandez-Mazarrasa, C. Garcia-Rey, E. Bouza, L. Aguilar, J. Garcia-de-Lomas, and F. Baquero. 2001. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:3334-3340.
29. Pozzi, G., R. A. Musmanno, P. M. Lievens, M. R. Oggioni, P. Plevani, and R. Manganelli. 1990. Method and parameters for genetic transformation of Streptococcus sanguis Challis. Res. Microbiol. 141:659-670.
30. Sambrook, J., E. J. Fritsch, and T. Maniatis. 1989. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Sifaoui, F., M. Kitzis, and L. Gutmann. 1996. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x. Antimicrob. Agents Chemother. 40:152-156.
32. Smith, A. M., and K. P. Klugman. 2001. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:2393-2396.
33. Smith, A. M., and K. P. Klugman. 2005. Amino acid mutations essential to production of an altered PBP 2X conferring high-level beta-lactam resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 49:4622-4627.
34. Tuohy, M., and J. A. Washington. 1997. Antimicrobial susceptibility of viridans group streptococci. Diagn. Microbiol. Infect. Dis. 29:277-280.
35. Utaida, S., P. M. Dunman, D. Macapagal, E. Murphy, S. J. Projan, V. K. Singh, R. K. Jayaswal, and B. J. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.